Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
AO

AORT

Market Closed

Artivion, Inc.

NYSEHealthcareMedical - Devices
US
1.80K employees
CEO: James Patrick Mackin
Founded: 1993
$23.09
+$0.00(+NaN%)
Market Cap
1.13B
Beta
1.22
52W Range
N/A
Dividend Yield
0.00%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Artivion's current price exceeds its PERT-weighted fair value by 12.9%, indicating potential overvaluation. High analyst targets contrast sharply with weak profitability and efficiency scores, signaling earnings challenges despite robust liquidity. Monte Carlo outcomes reveal significant downside risk, with all scenarios below current price, reflecting elevated volatility and uncertainty.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore AORT

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

AORT in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Devices

Browse industry stocks →